Phenomic AI Company

Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.The company's platform uses artificial intelligence to analyze phenotypes in complex disease models including high-content co-culture and 3D assays, enabling pharmaceutical companies to discover drugs in an easier way.
Technology: Artificial Intelligence, Biotechnology, Information Technology, Machine Learning
Industry: Early Drug Development
Headquarters: Toronto, Ontario, Canada
Founded Date: 2017-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 13
Total Funding: 11391214
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-10-07
Last Funding Type: Seed

Visit Website
Register and Claim Ownership